The Kaplan-Meier curve analyses showed that decreased BRD4 mRNA levels were significantly associated with overall survival (OS) and disease-free survival (DFS) in GBM patients (Figure 3; p < 0.01). The gene discussed is BRD4; the disease is glioblastoma.